Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Breast Neoplasms
  • Cardiomyopathies
  • Heart Failure

abstract

  • HF or CM are common complications after trastuzumab therapy for older women, with higher rates than those reported from clinical trials.

publication date

  • December 18, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2012.07.068

PubMed ID

  • 23158536

Additional Document Info

start page

  • 2504

end page

  • 12

volume

  • 60

number

  • 24